Remgro Stock

Remgro EBIT Growth

The Year-over-Year EBIT Growth of Remgro (REM.JO) as of Aug 25, 2026 is 18.48 %. In the previous year, Year-over-Year EBIT Growth was 14.91 % — a change of 23.92% (higher).

EBIT Growth

18.48 %

YoY

23.92%

Last updated:

Year-over-Year EBIT Growth of Remgro is 2026 18.48 % . Year-over-Year EBIT Growth of Remgro was 2025 14.91 % . It decreases by 23.92% higher compared to the previous year.

The Remgro EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
65.45 ZAR
Jan 1, 2019
159.65 ZAR
Jan 1, 2020
-52.80 ZAR
Jan 1, 2021
187.54 ZAR
Jan 1, 2022
13.72 ZAR
Jan 1, 2023
-53.80 ZAR
Jan 1, 2024
14.91 ZAR
Jan 1, 2025
18.48 ZAR
The Remgro EBIT Growth history
YEAREBIT GrowthYoY
18.48 %+23.92%
14.91 %-127.72%
-53.80 %-492.19%
13.72 %-92.69%
187.54 %-455.17%
-52.80 %-133.07%
159.65 %+143.95%
65.45 %+32.97%
49.22 %-173.22%
-67.22 %-150.49%
133.13 %—
Access this data via the Eulerpool API
Get Free API Key

Remgro Stock analysis

What does Remgro do? Remgro Ltd is a diversified company that offers a wide range of products and services in various business sectors. The company was founded in 1990 and is based in Stellenbosch, South Africa. The company emerged from the acquisition of Rembrandt Group Ltd, which was founded by South African billionaire and philanthropist Anton Rupert. Remgro has been a diversified company since its inception, operating in various business sectors. The company is divided into three main areas: finance, healthcare, and infrastructure. Some of the key holdings of Remgro in the finance sector include FirstRand Limited, RMB Holdings Limited, and Momentum Metropolitan Holdings Limited. In the healthcare sector, Remgro is active through its subsidiaries Mediclinic International plc and Erste Holdings Limited. Mediclinic operates clinics and hospitals in South Africa, the UK, and the UAE, offering a wide range of medical services. Erste Holdings is one of the largest pharmaceutical companies in South Africa, producing a wide range of medications and healthcare products. In the infrastructure sector, Remgro is involved through its stake in South African utility company PowerX, which is a leading provider of electricity and water in the country. Overall, Remgro is a diversified company operating in various sectors and offering a wide range of products and services. Remgro is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remgro stock

Year-over-Year EBIT Growth of Remgro is 18.48 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Remgro since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Remgro historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Growth — Remgro

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Remgro